Delhi HC Directs Centre to Release 14 Crores to Panacea Biotech for Manufacturing Vaccine - (07 Jun 2021)
CIVIL
Delhi High Court has directed the Centre to release an amount of Rs. 14 Crores along with the interest of 12% to Panacea Biotech for manufacturing Sputnik V subject to the condition of receiving permission from respective authorities to manufacture it in India.
Tags : DELHI HIGH COURT PANACEA BIOTECH MANUFACTURING OF SPUTNIK V VACCINE
Share :
|